Clinical Trial Detail
| NCT ID | NCT03559049 |
| Title | Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | University of Michigan Cancer Center |
| Indications | |
| Therapies |
Carboplatin + Pembrolizumab + Pemetrexed Disodium + Rucaparib |
| Age Groups: | senior adult |
CKB BOOST